使用稳定同位素标记 LC-TIMS-TOF MS/MS 从 头 追踪脂质
2024年8月23日
2.7K 次观看
这里介绍的是一种利用其保留时间、迁移率和碎裂通过稳定同位素标记来筛选脂质结构的方法。
本研究旨在使用稳定同位素标记在脂质组学样品中实现更特异性的定量。这使我们能够了解脂质面板和从昆虫到人类的高度多样化的样品。目前，该领域在脂质组学研究中 LC、TIMS、Top、MS/MS 的标准化方面存在差距。
在这里，我们提供了一种为此目的跟踪生物量遗骸的方法。未来，我们的研究将涉及使用 LC 团队工作人员 MS/MS 对生物过程中存在的表观遗传学和代谢组学进行调查，涉及 DDA 和 DIA 方法。
概览
这项研究提出了一种通过稳定同位素标记筛选脂质结构的方法，提高了脂质组样本的定量分析。该研究解决了脂质研究中LC-TIMS-TOF MS/MS标准化的不足。
关键研究组成部分
科学领域
- 神经科学
- 生物化学
- 质谱法
背景
- 不同物种的脂质组样本差异很大。
- 当前脂质分析缺乏标准化。
- LC-TIMS-TOF MS/MS是脂质分析的关键技术。
- 了解脂质面板可以帮助进行多种生物学研究。
研究目的
- 实施特定的脂质定量方法。
- 在脂质组研究中跟踪生物质残留。
- 探索表观遗传学和代谢组学的未来研究。
使用的方法
- 稳定同位素标记用于脂质定量。
- LC-TIMS-TOF MS/MS校准程序。
- 在质谱法中使用DDA和DIA方法。
- 分析从昆虫到人类的多样样本。
主要结果
- 开发了一种改进脂质结构筛选的方法。
- 确定了脂质分析中标准化的需求。
- 为相关领域的未来研究提供了框架。
- 展示了稳定同位素标记的应用。
结论
- 该方法增强了对脂质多样性的理解。
- 标准化对于推进脂质组学研究至关重要。
- 未来的研究将扩展到表观遗传学和代谢组学。
常见问题
什么是稳定同位素标记？
稳定同位素标记是一种用于追踪和定量生物样本中特定分子（如脂质）的技术。
为什么标准化在脂质分析中很重要？
标准化确保了不同研究和实验室之间结果的一致性和可靠性。
什么是LC-TIMS-TOF MS/MS方法？
LC-TIMS-TOF MS/MS指的是液相色谱与离子迁移谱和飞行时间质谱相结合，用于复杂混合物的详细分析。
这项研究如何影响未来的研究？
这项研究为更精确的脂质分析奠定了基础，并为探索表观遗传学和代谢组学开辟了途径。
这项研究分析了哪些类型的样本？
该研究分析了从昆虫到人类的一系列样本，以展示该方法的适用性。
Executive Industry Relevance
Stable isotope labeling combined with LC-TIMS-TOF MS/MS enables high-throughput, quantitative tracing of de novo lipid synthesis and dynamics in complex biological samples. This approach addresses the critical need for standardization and reproducibility in lipidomics, supporting confident target validation and mechanistic de-risking in early discovery. The protocol's ability to resolve lipid structures at the fatty acid chain level enhances predictive confidence for translational and preclinical research pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables precise interrogation of lipid metabolic pathways using stable isotope-labeled tracers.
- Supports functional target validation by quantifying de novo lipid synthesis and turnover.
- Reduces mechanistic ambiguity in lipid biology through high-resolution structural assignment.
- Facilitates portfolio triage by providing robust, quantitative lipidomic data.
Screening & Assay Development
- Prepares validated lipidomic systems for downstream screening workflows.
- Delivers standardized, reproducible, and quantitative outputs for assay development.
- Enables high-throughput screening readiness with single-sample, single-scan analysis.
- Supports reliable compound evaluation by minimizing endogenous interference.
Translational & Preclinical Research
- Aligns lipidomic measurements with disease-relevant biological processes, such as ovary development in model organisms.
- Provides continuity from discovery through preclinical validation by tracking lipid dynamics over time.
- Enables risk-adjusted advancement decisions based on quantitative biomarker data.
- Enhances predictive de-risking for translational biomarker strategies.
Pipeline & Workflow Integration
This method integrates from early discovery through lead identification and preclinical research, supporting hypothesis testing and quantitative pathway analysis in lipid metabolism.
- Discovery Biology: Facilitates hypothesis-driven interrogation of lipid synthesis and mobilization using SIL tracers.
- Screening: Provides assay-ready, reproducible, and quantitative lipidomic outputs for compound evaluation.
- Analytics: Delivers high-resolution measurements of retention time, mobility, and fragmentation for confident lipid assignment.
- Translational Research: Supports biomarker alignment and continuity across discovery and preclinical stages.
- Enterprise Reuse: Establishes a standardized, scalable workflow for lipidomics applicable across diverse biological systems.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and target validation by resolving lipid structure-function relationships.
- Operational Value: Drives standardization, reproducibility, and scalability in lipidomic analyses.
- Strategic Value: Enables informed go/no-go decisions and reduces late-stage biological risk through robust data.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of lipid-targeted programs.
Implementation Considerations
- Requires expertise in mass spectrometry, stable isotope labeling, and lipidomics data analysis.
- Demands access to LC-TIMS-TOF MS/MS instrumentation and advanced analytical software.
- Necessitates rigorous calibration and cross-team standardization for reproducible results.
- Adaptable to various biological models but may require optimization for specific sample types.
- Potential limitations include the need to minimize endogenous interference and ensure accurate isotope enrichment calculations.
Biopharma FAQs
Why does null hypothesis testing matter for SIL lipid quantification?
Null hypothesis testing ensures that observed changes in labeled lipid abundance are statistically significant, supporting confident target validation and reducing false positives in lipidomics-driven discovery.
How does independent variable isolation fit LC-TIMS-TOF MS/MS workflows?
Isolating variables such as specific lipid species or isotope-labeled tracers enables precise attribution of metabolic changes, enhancing mechanistic clarity and supporting robust discovery-stage decisions.
What do quantitative dependent variable measurements enable in lipidomics?
Quantitative measurements of retention time, mobility, and fragmentation patterns allow for confident lipid identification and dynamic profiling, facilitating reliable comparison across experimental conditions.
Why are replication requirements critical for cross-functional lipidomics studies?
Replication ensures reproducibility and comparability of lipidomic data across teams, supporting collaborative assay development and consistent decision-making in multi-site R&D environments.
What statistical analysis capabilities are required before implementing SIL LC-TIMS-TOF MS/MS?
Robust statistical tools are needed to assess calibration accuracy, isotope enrichment, and measurement error, ensuring data quality and supporting actionable insights for pipeline advancement.
